Xcout Intel
Geltor
Geltor is an Emeryville, California-based biotechnology research company powered by its Biodesigner AI™ platform to create sustainable, animal-free specialty proteins for beauty, personal care, and nutrition markets.
Subscribe to see Geltor’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Geltor at a glance
Geltor is a biotechnology company headquartered in United States. It has raised at least $109.5M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $91.3M in July 2020. Xcout tracks 2 named people at Geltor, including Alex Lorestani (CEO and co-founder).
Geltor leadership
- Alex LorestaniCEO and co-founder
- Nick OuzounovCo-Founder
Geltor funding rounds
At least $109.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $91.3M | 2 named | |
| Series A | $18.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Geltor competitors
A few of Geltor's closest competitors — see the full list of competitors and alternatives →
Nuritas uses a proprietary AI platform to discover, validate, and supply natural peptide ingredients for oral and topical health and wellness formulations. The company serves health and wellness brands by providing clinically-backed ingredients and custom peptide discovery services.
Genvor Inc utilizes an AI-accelerated peptide platform to develop sustainable agricultural solutions and human health wellness products. The company serves agricultural partners through licensing and co-development to improve crop protection, stress tolerance, and yields, while also providing targeted peptide products for consumer recovery, performance, anti-aging, and daily wellness.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Earendil Labs is an AI-powered drugmaker and protein therapeutics discovery company headquartered in Middletown, Delaware, with offices in China. The company develops technology platforms that transform the discovery of protein therapeutics using deep learning and high-throughput biology, and has raised significant venture backing.
Gordian Biotechnology is a biotechnology research company headquartered in South San Francisco, California. The company focuses on curing age-related diseases through in vivo target discovery and functional genomics platforms.
Amyris, Inc. is a vertically integrated biomanufacturing company that converts plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products using precision fermentation.
Get Geltor's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Geltor in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access